Aardvark Therapeutics NASDAQ:AARD Aardvark Therapeutics is a clinical stage biopharmaceutical company focused on leveraging host adaptive responses through gut-brain signaling for the treatment of metabolic and inflammatory diseases. The company has multiple programs in its pipeline and has received FDA orphan drug designation for its novel drug candidate for Prader-Willi syndrome.

Location: San Diego, California, United States | Website: https://aardvarktherapeutics.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing